A drug discovery engine that pairs covalent chemistry across all nucleophilic amino acid residues with chemical biology and cancer biology to generate small-molecule candidates against targets without conventional binding pockets, including intrinsically disordered proteins, scaffolding proteins, transcription factors, paralogs and protein-protein interfaces.